Key terms
About TENX
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TENX news
Feb 24
10:06am ET
Tenax Therapeutics Meets Nasdaq’s Float Requirement Compliance
Feb 20
11:50am ET
Tenax negotiates global levosimendan rights, says Roth MKM
Feb 20
8:46am ET
Tenax announces global license amendment, expands rights to levosimendan
Feb 20
8:42am ET
Tenax Therapeutics Amends Global Rights Deal with Orion
Feb 12
5:04pm ET
Tenax Therapeutics Raises $9M in Public Offering and Warrants
Feb 09
11:12am ET
Biotech Alert: Searches spiking for these stocks today
Feb 08
11:40am ET
Biotech Alert: Searches spiking for these stocks today
Feb 08
8:20am ET
Tenax Therapeutics prices 1.6M shares at $5.65 in public offering
Feb 07
8:08pm ET
Tenax Therapeutics enrolls first patient in Phase 3 study of TNX-103
Feb 07
9:36am ET
Tenax Therapeutics trading resumes
Feb 07
9:31am ET
Tenax Therapeutics trading halted, volatility trading pause
Feb 07
4:21am ET
Tenax Therapeutics Granted Patent for Heart Treatment Drugs
Feb 06
9:38am ET
Tenax Therapeutics trading resumes
Feb 06
9:33am ET
Tenax Therapeutics trading halted, volatility trading pause
Feb 06
8:42am ET
Tenax announces USPTO grants notice of allowance for patent application
Jan 02
7:50pm ET
Tenax Therapeutics trading halted, news pending
Dec 29
8:30am ET
Tenax Therapeutics announces 1-for-80 reverse stock split
No recent press releases are available for TENX
TENX Financials
Key terms
Ad Feedback
TENX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TENX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range